Core Insights - Lumexa Imaging Holdings, Bluerock Acquisition, and Carbon Capital Partners collectively raised $913 million upon their NASDAQ debut on December 11 [1] - Lumexa Imaging Holdings opened at $18.65 per share, slightly above its offering price, and closed at $18.52, with a total market capitalization of $1.751 billion [1][4] - Lumexa Imaging reported revenues of $755 million and a net loss of $18.41 million for the nine months ending September 30, 2025 [4] New Listings - Lumexa Imaging Holdings (LMRI) raised $463 million by issuing 25 million shares at $18.50 each, with funds allocated for repaying existing loans and general corporate purposes [4] - Bluerock Acquisition (BLRKU) and Carbon Capital Partners (KBONU) also listed on the same day, raising $150 million and $300 million respectively [5] IPO Filings - Brand Meditech Limited, a Chinese company, filed for an IPO with plans to list on NASDAQ under the ticker AED, aiming to raise between $6.3 million and $8.1 million by offering 900,000 shares at $7 to $9 each [6][10] - Brand Meditech specializes in medical devices and software, including infusion pumps and portable X-ray machines, targeting various medical fields [10] Financial Data - For the fiscal years ending March 31, 2024, and 2025, Brand Meditech reported revenues of $2.619 million and $2.549 million, with net profits of $1.47 million and $1.21 million respectively [11]

Core Viewpoint - Lumexa Imaging, a provider of outpatient imaging diagnostic services, has successfully launched on the US stock market with an opening price of $18.8, slightly above its IPO price of $18.5 [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the US [1] - The company was co-founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, starting with only 20 centers [1] - Lumexa Imaging has expanded through 20 acquisitions and the establishment of 41 new locations [1] Services Offered - The company provides a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] Network and Partnerships - Lumexa Imaging has developed a diversified referral network, collaborating with over 29,000 medical institutions and approximately 100,000 physicians [1] Financial Performance - The company reported projected sales of $1 billion for the 12 months ending September 30, 2025 [1]

Core Viewpoint - Lumexa Imaging, a provider of outpatient imaging diagnostic services, has successfully launched on the US stock market with an opening price of $18.8, slightly above its IPO price of $18.5 [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the US [1] - The company was founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, starting with only 20 centers [1] - Lumexa Imaging has expanded through 20 acquisitions and the establishment of 41 new locations [1] Services Offered - The company provides a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] Network and Partnerships - Lumexa Imaging has developed a diversified referral network, collaborating with over 29,000 healthcare institutions and approximately 100,000 physicians [1] Financial Performance - The company reported a sales figure of $1 billion for the 12 months ending September 30, 2025 [1]

Core Insights - Lumexa Imaging (LMRI.US) debuted on the US stock market with an opening increase of over 1.6%, trading at $18.8, after an IPO price of $18.5 [1] Company Overview - Lumexa Imaging is a national outpatient diagnostic imaging service provider based in North Carolina, operating 184 diagnostic centers across 13 states in the US [1] - The company offers a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] - Founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, Lumexa Imaging initially started with 20 centers and has since expanded through 20 acquisitions and the opening of 41 new locations [1] Business Network and Financials - Lumexa Imaging has established a diversified referral network, collaborating with over 29,000 medical institutions and approximately 100,000 physicians [1] - The company reported projected sales of $1 billion for the 12 months ending September 30, 2025 [1]

Core Viewpoint - Lumexa Imaging's shares experienced a slight increase during their debut on Nasdaq, leading to a market valuation of $1.76 billion for the company [1] Company Summary - Lumexa Imaging is a provider of diagnostic imaging services [1] - The company's market valuation reached $1.76 billion following its initial public offering [1]

Core Insights - Lumexa Imaging is making its public debut by raising $462.5 million in its IPO [1] - The company operates 184 diagnostic centers across 13 states [1] - Lumexa Imaging will begin trading on the Nasdaq under the ticker LMRI [1] - CEO Caitlin Zulla discussed the company's debut on Bloomberg Open Interest [1]

Core Viewpoint - Lumexa Imaging Holdings is set to raise $463 million by issuing 25 million shares at a price of $18.50 each, with a market capitalization of $1.8 billion post-listing [1] Company Overview - Lumexa Imaging Holdings is a national provider of outpatient diagnostic imaging services in the United States, operating 184 imaging centers across 13 states through wholly-owned sites and joint ventures with healthcare systems [1] - The company offers a range of advanced and routine imaging equipment, including MRI, CT, PET scans, X-rays, ultrasounds, and mammography [1] Financial Projections - For the 12 months ending September 30, 2025, Lumexa is projected to achieve sales of $1 billion [1] Listing Details - The company plans to list on NASDAQ under the ticker symbol "LMRI" [1] - The joint bookrunners for this offering include Barclays, JPMorgan, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, and Raymond James [1]

Core Points - Lumexa Imaging Holdings, Inc. has announced the pricing of its initial public offering (IPO) at $18.50 per share for 25,000,000 shares of common stock [1] - The IPO includes a 30-day option for underwriters to purchase an additional 3,750,000 shares [1] - Trading is expected to commence on the Nasdaq Global Select Market under the symbol "LMRI" on December 11, 2025, with the offering closing on December 12, 2025, pending customary closing conditions [1] Company Overview - Lumexa Imaging is a nationwide provider of diagnostic imaging services, operating the second largest outpatient imaging center footprint in the United States as of September 30, 2025 [5] - The company operates 184 centers across 13 states and has eight joint venture partnerships with health systems [5]

Lumexa Imaging Holdings (LMRI) is now open for pre-IPO orders!Early Bird access is available for a limited time ahead of LMRI’s expected IPO on Dec 11, 2025.Set your limit price and get notified when trading begins. 🔔Secure your spot early 👇https://t.co/Q6C38J1EJ3 https://t.co/prDTunlTZb ...

Core Viewpoint - Lumexa Imaging Holdings, a provider of outpatient imaging diagnostic services in the U.S., announced its initial public offering (IPO) terms, aiming to raise $463 million by offering 25 million shares at a price range of $17-20 per share [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the U.S. through wholly-owned operations and joint ventures with healthcare systems [1] - The company offers a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] - Founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, Lumexa started with only 20 centers and has expanded through 20 acquisitions and the opening of 41 new locations [1] Business Network and Financials - Lumexa Imaging has established a diversified referral network, collaborating with over 29,000 healthcare providers and employing approximately 100,000 individuals [1] - The company reported sales of $1 billion for the 12 months ending September 30, 2025 [1]